DELCATH SYSTEMS, INC.

DCTH ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $29.1M $25.0M $20.7M $20.6M $24.2M $19.8M $15.1M $11.2M
Cost of Revenue $3.0M $3.7M $3.0M $2.6M $3.3M $2.8M $2.1M $1.6M
Gross Profit $26.1M $21.3M $17.7M $17.9M $20.8M $16.9M $13.0M $9.6M
Gross Margin 89.8% 85.1% 85.5% 87.2% 86.3% 85.6% 85.9% 85.4%
Operating Expenses
Research & Development $10.4M $9.8M $9.4M $8.0M $6.9M $5.0M $2.9M $3.9M
SG&A Expense $13.4M $13.1M $10.5M $10.3M $11.4M $11.3M $7.0M $7.0M
Operating Income $2.4M $-1.6M $-2.2M $-388.0K $2.6M $642.0K $3.0M $-1.3M
Operating Margin 8.2% -6.5% -10.5% -1.9% 10.7% 3.2% 20.1% -11.2%
Interest Expense — — — — — — — —
Pretax Income $3.2M $-908.0K $-1.3M $375.0K $3.2M $1.3M $-3.4M $1.9M
Income Tax Expense $491.0K $162.0K $562.0K $-455.0K $508.0K $195.0K $0 $0
Net Income $2.7M $-1.1M $-1.9M $830.0K $2.7M $1.1M $-3.4M $1.9M
Net Margin 9.2% -4.3% -9.1% 4.0% 11.2% 5.4% -22.5% 16.6%
EPS (Basic) $0.07 $-0.03 $-0.05 $0.02 $0.08 $0.03 $-0.06 $0.06
EPS (Diluted) $0.07 $-0.03 $-0.05 $0.02 $0.07 $0.03 $-0.06 $0.06
Shares Outstanding (Basic) 35.9M 36.0M 35.8M 36.4M 35.8M 34.6M 28.5M 28.7M
Shares Outstanding (Diluted) 39.8M 36.0M 39.9M 40.1M 40.3M 39.5M 28.5M 32.3M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 6 Older →